XML 17 R7.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Cash flows from operating activities        
Net (loss)/ income $ (7,377) $ 8,054 $ (7,487) $ 24,702
Adjustments to reconcile net (loss)/income to net cash provided by operating activities:        
Depreciation and amortization 1,994 1,641 5,842 4,664
Equity-based compensation     21,961 258
Non-cash interest expense; amortization of debt costs 200 200 706 399
Loss on debt modification 0 0 0 682
(Gain)/loss on disposal of long-lived assets (12) 0 215 0
Changes in assets and liabilities        
Prepaid expense and other current assets     2,079 (604)
Other assets     (8,165) (1,585)
Accounts payable     (287) 291
Deferred revenue and patient deposits     (589) 1,100
Accrued and other liabilities     3,532 2,432
Net cash provided by operating activities     17,807 32,339
Cash flows from investing activities        
Purchases of property and equipment, net     (10,726) (4,726)
Net cash used in investing activities     (10,726) (4,726)
Cash flows from financing activities        
Payment on term loan     (637) (626)
Borrowings on term loan, net     0 49,994
Distribution to member     (1,159) (66,622)
Dividends paid to shareholders (22,800)   (22,812) 0
Payment of deferred loan costs     (220) 0
Net cash used in financing activities     (24,828) (17,254)
Net (decrease)/increase in cash and cash equivalents     (17,747) 10,359
Cash and cash equivalents        
Beginning of period     25,347 10,379
End of period $ 7,600 $ 20,738 7,600 20,738
Supplemental disclosure of cash flow information:        
Cash paid for interest     4,116 2,722
Cash paid for taxes     4,368 0
Supplemental disclosure of non-cash investing information:        
Property and equipment included in accounts payable and accrued expenses     $ 695 $ 0